CNSY
Price:
$2.03
Market Cap:
$13.97M
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Industry
Medical - Pharmaceuticals
IPO Date
2026-08-03
Stock Exchange
NASDAQ
Ticker
CNSY
According to Cerenome, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.48. This represents a change of -28.89% compared to the average of -0.68 of the last 4 quarters.
The mean historical PE Ratio of Cerenome, Inc. over the last ten years is -0.06. The current -0.48 PE Ratio has changed 74.15% with respect to the historical average. Over the past ten years (40 quarters), CNSY's PE Ratio was at its highest in in the June 2025 quarter at 0.00. The PE Ratio was at its lowest in in the December 2025 quarter at -0.97.
Average
-0.06
Median
-0.00
Minimum
-0.56
Maximum
-0.00
Discovering the peaks and valleys of Cerenome, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 217.34%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -0.56
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.56 | 578.03% |
| 2024 | -0.08 | 217.34% |
| 2023 | -0.00 | 172.41% |
| 2022 | -0.00 | 53.94% |
| 2021 | -0.00 | 56.92% |
| 2020 | -0.00 | 344.62% |
| 2019 | -0.00 | 951.75% |
| 2018 | -0.00 | 302.68% |
| 2017 | -0.00 | 82.72% |
| 2016 | -0.00 | 56.21% |
The current PE Ratio of Cerenome, Inc. (CNSY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.22
5-year avg
-0.13
10-year avg
-0.06
Cerenome, Inc.’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cerenome, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cerenome, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cerenome, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cerenome, Inc. (CNSY)?
What is the highest PE Ratio for Cerenome, Inc. (CNSY)?
What is the 3-year average PE Ratio for Cerenome, Inc. (CNSY)?
What is the 5-year average PE Ratio for Cerenome, Inc. (CNSY)?
How does the current PE Ratio for Cerenome, Inc. (CNSY) compare to its historical average?